Weekly Injections Semaglutide has shown promising results in clinical trials for weight loss, with participants losing an average of 10% to 15% of their body weight over 16 to 72 weeks, depending on the dosage and individual factors
FDA Clarifies Policies as National GLP-1 Supply Begins to Stabilize . Available at: FDA.gov McDermott Will & Emery
But these days fewer people are relying solely on dieting or going to the gym -- instead, theyre taking a shot of a drug called Semaglutide
Mollan, MBChB, FRCOphth, PhD Honorary professor, University of Birmingham, EnglandConsultant neuro-ophthalmologist, University Hospitals Birmingham, England Disclosures: Mollan reports receiving grants or research income paid to her institution from National Institute of Health Research, UK Space Agency and Idiopathic Intracranial Hypertension UK